Congressional investigations may be uncovering instances of unreported financial conflicts of interest that researchers have and NIH may be asking for comment on more stringent regulations, but how those conflicts are managed is complex, says a Science Progress article. Furthermore, it adds that while the proposed new rules "support greater disclosure and transparency," the rules "fail to address other complex matters" such as institutions that have industry support, financial interests from lectures, and from tech transfer arrangements. "Overall the challenge remains the same—how do we continue to encourage public/private partnerships so that translational research can continue to move forward at a rapid pace without compromising research integrity?" the article asks.